Genome Sequence of Mannheimia haemolytica Serotype 1 Strain 16041065 BH

Sahlu Ayalew1, Anthony W Confer1, Richard D Hansen2

  • 1Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.

Genome Announcements
|April 8, 2017
PubMed

Insights

We sequenced the genome of Mannheimia haemolytica serotype 1 strain 16041065 BH, isolated from a calf with pneumonia. The genome was 2.7 Mb and the strain showed hemolytic activity.

Area of Science:

  • Veterinary Microbiology
  • Genomics
  • Bacterial Pathogenesis

Background:

  • Mannheimia haemolytica is a significant bacterial pathogen causing pneumonia in cattle.
  • Bovine respiratory disease complex (BRDC) leads to substantial economic losses in the livestock industry.
  • Understanding the genetic makeup of M. haemolytica strains is crucial for developing effective control strategies.

Purpose of the Study:

  • To report the complete genome sequence of Mannheimia haemolytica serotype 1 strain 16041065 BH.
  • To characterize the genomic features and hemolytic activity of this specific strain.
  • To provide a genomic resource for future research on M. haemolytica virulence and host-pathogen interactions.

Main Methods:

  • Whole-genome sequencing of M. haemolytica serotype 1 strain 16041065 BH.
  • Bioinformatic analysis to assemble and annotate the genome.
  • Phenotypic testing of hemolytic activity on blood heart infusion agar.

Main Results:

  • The genome sequence of M. haemolytica serotype 1 strain 16041065 BH was successfully obtained.
  • The genome size is approximately 2.7 Mb with an N50 of 122 kb.
  • The strain exhibited significant hemolytic activity when cultured on blood agar.

Conclusions:

  • The availability of this genome sequence provides valuable insights into the genetic basis of M. haemolytica virulence.
  • This genomic data can aid in understanding the pathogenesis of M. haemolytica-induced pneumonia in cattle.
  • Further studies utilizing this genome sequence may contribute to improved diagnostics and therapeutics for BRDC.